By Associate Professor Preeyaporn Srasuebkul

Journal articles

Jacoby P; Wong K; Srasuebkul P; Glasson EJ; Forbes D; Ravikumara M; Wilson A; Nagarajan L; Bourke J; Trollor J; Leonard H; Downs J, 2020, 'Risk of Hospitalizations Following Gastrostomy in Children with Intellectual Disability', Journal of Pediatrics, 217, pp. 131 - 138.e10, http://dx.doi.org/10.1016/j.jpeds.2019.10.020

Hwang YI; Arnold S; Srasuebkul P; Trollor J, 2020, 'Understanding anxiety in adults on the autism spectrum: An investigation of its relationship with intolerance of uncertainty, sensory sensitivities and repetitive behaviours', Autism, 24, pp. 411 - 422, http://dx.doi.org/10.1177/1362361319868907

Reppermund S; Srasuebkul P; Dean K; Trollor JN, 2020, 'Factors associated with death in people with intellectual disability.', J Appl Res Intellect Disabil, 33, pp. 420 - 429, http://dx.doi.org/10.1111/jar.12684

Reppermund S; Heintze T; Srasuebkul P; Reeve R; Dean K; Smith M; Emerson E; Snoyman P; Baldry E; Dowse L; Szanto T; Sara G; Florio T; Johnson A; Clements M; McKenzie K; Trollor J, 2019, 'Health and wellbeing of people with intellectual disability in New South Wales, Australia: A data linkage cohort', BMJ Open, 9, pp. e031624, http://dx.doi.org/10.1136/bmjopen-2019-031624

Ee D; Hwang YI; Reppermund S; Srasuebkul P; Trollor JN; Foley K-R; Arnold SRC; Hwang J, 2019, 'Loneliness in Adults on the Autism Spectrum', Autism in Adulthood, 1, pp. 182 - 193, http://dx.doi.org/10.1089/aut.2018.0038

Hwang YI; Srasuebkul P; Foley KR; Arnold S; Trollor JN; Hwang J, 2019, 'Mortality and cause of death of Australians on the autism spectrum', Autism Research, 12, pp. 806 - 815, http://dx.doi.org/10.1002/aur.2086

Wong K; Leonard H; Pearson G; Glasson EJ; Forbes D; Ravikumara M; Jacoby P; Bourke J; Srasuebkul P; Trollor J; Wilson A; Nagarajan L; Downs J, 2019, 'Epidemiology of gastrostomy insertion for children and adolescents with intellectual disability', European Journal of Pediatrics, 178, pp. 351 - 361, http://dx.doi.org/10.1007/s00431-018-3304-x

Glasson EJ; Wong K; Leonard H; Forbes D; Ravikumara M; Mews C; Jacoby P; Bourke J; Trollor J; Srasuebkul P; Wilson A; Nagarajan L; Downs J, 2018, 'Evolving Trends of Gastrostomy Insertion Within a Pediatric Population', Journal of Pediatric Gastroenterology and Nutrition, 67, pp. e89 - e94, http://dx.doi.org/10.1097/MPG.0000000000002042

Langton JM; Goldsbury D; Srasuebkul P; Ingham JM; O'Connell DL; Pearson SA, 2018, 'Insights from linking routinely collected data across Australian health jurisdictions: a case study of end-of-life health service use', Public Health Research and Practice, 28, pp. e2811806 - e2811806, http://dx.doi.org/10.17061/phrp2811806

Li X; Srasuebkul P; Reppermund S; Trollor J; Li XS, 2018, 'Emergency department presentation and readmission after index psychiatric admission: A data linkage study', BMJ Open, 8, pp. e018613, http://dx.doi.org/10.1136/bmjopen-2017-018613

Joshi V; Adelstein BA; Schaffer A; Srasuebkul P; Dobbins T; Pearson SA, 2017, 'Validating a proxy for disease progression in metastatic cancer patients using prescribing and dispensing data', Asia Pacific Journal of Clinical Oncology, 13, pp. e246 - e252, http://dx.doi.org/10.1111/ajco.12602

Reppermund S; Srasuebkul P; Heintze T; Reeve R; Dean K; Emerson E; Coyne D; Snoyman P; Baldry E; Dowse L; Szanto T; Sara G; Florio T; Trollor JN, 2017, 'Cohort profile: A data linkage cohort to examine health service profiles of people with intellectual disability in New South Wales, Australia', BMJ Open, 7, pp. e015627, http://dx.doi.org/10.1136/bmjopen-2016-015627

Trollor J; Srasuebkul P; Xu H; Howlett S, 2017, 'Cause of death and potentially avoidable deaths in Australian adults with intellectual disability using retrospective linked data', BMJ Open, 7, pp. e013489, http://dx.doi.org/10.1136/bmjopen-2016-013489

Reeve R; Srasuebkul P; Langton J; Haas M; Viney R; Pearson S, 2017, 'Health care use and costs at the end of life: a comparison of elderly Australian decedents with and without a cancer history', BMC Palliative Care, 17, pp. 1, http://dx.doi.org/10.1186/s12904-017-0213-0

Parkinson B; Viney R; Haas M; Goodall S; Srasuebkul P; Pearson SA, 2016, 'Real-World Evidence: A Comparison of the Australian Herceptin Program and Clinical Trials of Trastuzumab for HER2-Positive Metastatic Breast Cancer', Pharmacoeconomics, 34, pp. 1039 - 1050, http://dx.doi.org/10.1007/s40273-016-0411-2

Langton JM; Reeve R; Srasuebkul P; Haas M; Viney R; Currow D; Pearson S-A, 2016, 'Health service use and costs in the last 6 months of life in elderly decedents with a history of cancer: a comprehensive analysis from a health payer perspective', British Journal of Cancer, 114, pp. 1293 - 1302, http://dx.doi.org/10.1038/bjc.2016.75

Pearson SA; Abrahamowicz M; Srasuebkul P; Buckley NA, 2015, 'Antidepressant therapy in cancer patients: Initiation and factors associated with treatment', Pharmacoepidemiology and Drug Safety, 24, pp. 600 - 609, http://dx.doi.org/10.1002/pds.3753

Langton J; Srasuebkul P; Reeve R; Parkinson B; Gu Y; Buckley N; Haas M; Viney R; Pearson S, 2015, 'Resource use, costs and quality of end of life care: Observations in a cohort of elderly Australian cancer decedents', Implementation Science, 10, http://dx.doi.org/10.1186/s13012-014-0148-2

Pearce A; Haas M; Viney R; Haywood P; Pearson S-A; van Gool K; Srasuebkul P; Ward R, 2015, 'Can administrative data be used to measure chemotherapy side effects?', Expert Review of Pharmacoeconomics & Outcomes Research, 15, pp. 215 - 222, http://dx.doi.org/10.1586/14737167.2015.990888

Van Leeuwen MT; Turner JJ; Joske DJ; Falster MO; Srasuebkul P; Meagher NS; Grulich AE; Giles GG; Vajdic CM, 2014, 'Lymphoid neoplasm incidence by WHO subtype in Australia 1982-2006', International Journal of Cancer, 135, pp. 2146 - 2156, http://dx.doi.org/10.1002/ijc.28849

Joshi V; Adelstein B-A; Schaffer A; Srasuebkul P; Dobbins T; Pearson S-A, 2013, 'A Proxy of Cancer Progression in Dispensing Claims: Validation and Performance', PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 22, pp. 221 - 222, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000334876101022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Langton JM; Srasuebkul P; Buckley NA; Pearson S-A, 2013, 'Prescription Drug Use in the Last 12 Months of Life: Observations in a Cohort of Elderly Patients', PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 22, pp. 352 - 352, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000334876101270&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lu CY; Srasuebkul P; Drew AK; Ward RL; Pearson SA, 2012, 'Positive spillover effects of prescribing requirements: Increased cardiac testing in patients treated with trastuzumab for HER2+ metastatic breast cancer', Internal Medicine Journal, 42, pp. 1229 - 1235, http://dx.doi.org/10.1111/j.1445-5994.2011.02604.x

Joshi V; Adelstein B-A; Srasuebkul P; Dobbins T; Pearson S-A, 2012, 'Estimating Disease Progression in Metastatic Cancer Patients Using Dispensing Data: A Validation Study', PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 21, pp. 169 - 169, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308131701347&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Brown DA; Hance KW; Rogers CJ; Sansbury LB; Albert PS; Murphy G; Laiyemo AO; Wang Z; Cross AJ; Schatzkin A; Danta M; Srasuebkul P; Amin J; Law M; Breit SN; Lanza E, 2012, 'Serum Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15): A Potential Screening Tool for the Prevention of Colon Cancer?', Cancer Epidemiology, Biomarkers & Prevention, 21, pp. 337 - 346, http://dx.doi.org/10.1158/1055-9965.epi-11-0786

Puls R; Srasuebkul P; Petoumenos K; Boesecke C; Duncombe CJ; Belloso WH; Molina J; Li L; Avihingsanon A; Gazzard B; Cooper DA; Emery S, 2010, 'Efavirenz versus boosted atazanavir or zidovudine and abacavir in antirectroviral treatment-naive, HIV-infected subjects: week 48 data from the Altair study', Clinical Infectious Diseases, Oct 1; 51, pp. 855 - 864

Srasuebkul P; Sungkanuparph S; Lim PL; Law MG, 2009, 'Reply to DiNubile', Clinical Infectious Diseases, 49, pp. 811 - 812, http://dx.doi.org/10.1086/605290

Srasuebkul P; Lim PL; Lee MP; Kumarasamy N; Zhou J; Sirisanthana T; Li PCK; Kamarulzaman A; Oka S; Phanuphak P; Vonthanak S; Merati TP; Chen YMA; Sungkanuparph S; Tau G; Zhang F; Lee CKC; Ditangco R; Pujari S; Choi JY; Smith J; Law' MG, 2009, 'Short-term clinical disease progression in hiv-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV Observational database', Clinical Infectious Diseases, 48, pp. 940 - 950, http://dx.doi.org/10.1086/597354

Pujari S; Srasuebkul P; Sungkanuparph S; Lim PL; Kumarasamy N; Chuah J; Kumar R; Oka S; Choi J; Lee M; Phanuphak P; Kamarulzaman A; Lee C; Fujie Z; Ditangco R; Saphonn V; Sirisanthana T; Merati T; Law MG, 2009, 'Patient characteristics and treatment outcome associated with Protease Inhibitor (PI) use in the Asia-Pacific region', Journal of Antivirals & Antiretrovirals, 1, pp. 28 - 035, http://dx.doi.org/10.4172/jaa.1000004

Pujari S; Sungkanuparph S; Srasuebkul P; Lim P; Kumarasamy N; Chuah J; Kumar R; Phanuphak P, 2008, 'Patient characteristics and treatment outcomes associated with protease inhibitor (PI) use in the Asia-Pacific region', Journal of the International AIDS Society, 11, pp. p72, http://dx.doi.org/10.1186/1758-2652-11-s1-p72

Nuesch R; Ananworanich J; Srasuebkul P; Chetchotisakd P; Prasithsirikul W; Klinbuayam W; Mahanontharit A; Jupimai T; Ruxrungtham K; Hirschel B, 2008, 'Interruptions of tenofovir/emtricitabine based ART in patients with HIV/HBV co-infection', AIDS, 22, pp. 152 - 154

Nuesch R; Ananworanich J; Srasuebkul P; Chetchotisakd P; Prasithsirikul W; Klinbuayam W; Mahanontharit A; Jupimai T; Ruxrungtham K; Hirschel B, 2008, 'Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection', AIDS, 22, pp. 152 - 154

Srasuebkul P; Calmy A; Zhou J; Kumarasamy N; Law M; Lim PL, 2007, 'Impact of drug classes and treatment availability on the rate of antiretroviral treatment change in the TREAT Asia HIV Observational Database (TAHOD)', AIDS Research and Therapy, 4, http://dx.doi.org/10.1186/1742-6405-4-18

Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG, 2007, 'Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment', HIV Medicine, 8, pp. 46 - 54, http://dx.doi.org/10.1111/j.1468-1293.2007.00427.x

Huffam SE; Srasuebkul P; Zhou J; Calmy A; Saphonn V; Kaldor JM; Ditangco R, 2007, 'Prior antiretroviral therapy experience protects against zidovudine-related anaemia', HIV Medicine, 8, pp. 465 - 471

Boyd MA; Carr A; Ruxrungtham K; Srasuebkul P; Bien D; Law M; Wangsuphachart S; Krisanachinda A; Lerdlum S; Lange JMA; Phanuphak P; Cooper DA; Reiss P, 2006, 'Changes in body composition and mitochondrial nucleic acid content in patients switched from failed nucleoside analogue therapy to ritonavir-boosted indinavir and efavirenz', Journal of Infectious Diseases, 194, pp. 642 - 650, http://dx.doi.org/10.1086/505709

Boyd MA; Srasuebkul P; Khongphattanayothin M; Ruxrungtham K; Hassink EA; Duncombe CJ; Ubolyam S; Burger DM; Reiss P; Stek M; Lange JM; Cooper DA; Phanuphak P, 2006, 'Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients: a randomized, open-label trial with 112 weeks of follow-up (HIV-NAT 005).', Antiviral Therapy, 11, pp. 223 - 232

Nuesch R; Srasuebkul P; Ananworanich J; Ruxrungtham K; Phanuphak P; Duncombe CJ, 2006, 'Monitoring the toxicity of antiretroviral therapy in resource limited settings: a prospective clinical trial cohort in Thailand', Journal of Antimicrobial Chemotherapy, 58, pp. 637 - 644

Boyd MA; Srasuebkul P; Ruxrungtham K; Mackenzie P; Uchaipichat V; Stek M; Lange JM; Phanuphak P; Cooper DA; Udomuksorn W; Miners JO, 2006, 'Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir', Pharmacogenetics and Genomics, 16, pp. 321 - 329

Cardiello P; Hassink EA; Ananworanich J; Srasuebkul P; Samor TM; Mahanontharit A; Ruxrungtham K; Hirschel B; Lange JM; Phanuphak P; Cooper DA, 2005, 'A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection', Clinical Infectious Diseases, 40, pp. 594 - 600

Cardiello P; Srasuebkul P; Hassink EA; Mahanontharit A; Samor TM; Ruxrungtham K; Lange JM; Cooper DA; Phanuphak P, 2005, 'The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy', HIV Medicine, 6, pp. 122 - 128

Ungsedhapand C; Srasuebkul P; Cardiello P; Ruxrungtham K; Ratanasuwan W; Kroon E; Tongtalung M; Juengprasert N; Ubolyam S; Siangphoe U; Emery S; Lange JM; Cooper DA; Phanuphak P, 2004, 'Three-year durability of dual-nucleoside versus triple-nucleoside therapy in a Thai population with HIV infection', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 36, pp. 693 - 701

Ananworanich J; Nuesch R; Teeratakulpisarn S; Srasuebkul P; Chuenyam T; Siangphoe U; Ungsedhapand C; Phanuphak P; Ruxrungtham K, 2003, 'In vivo cell-mediated immunity in subjects with undetectable viral load on protease inhibitor-based versus non-protease inhibitor-based highly active antiretroviral therapy', Journal of Acquired Immune Deficiency Syndrome, 32, pp. 570 - 572

Pothikamjorn SL; Ruxrungtham K; Thampanitchawong P; Fuangthong R; Srasuebkul P; Sangahsapaviriyah A; Suttithavil W; Klaewsongkram J; Parisuthikul V; Viravan T; Rumsaeng V; Kana K; Direkwattanachai C; Kamchaisathien V; Phanupak P, 2002, 'Impact of particulate air pollutants on allergic diseases, allergic skin reactivity and lung function', Asia Pacific Journal of Allergy and Immunology, 20, pp. 77 - 83

Cardiello PG; van Heeswijk RP; Hassink EA; Srasuebkul P; Mahanontharit A; Samor TM; Worarien W; Beijnen JH; Hoetelmans RM; Ruxrungtham K; Cooper DA; Lange JM; Phanuphak P, 2002, 'Simplifying Protease Inhibitor Therapy with Once-Daily Dosing of Saquinavir Soft-Gelatin Capsules/Ritonavir (1600/100 mg): HIVNAT 001.3 Study', JAIDS Journal of Acquired Immune Deficiency Syndromes, 29, pp. 464 - 470, http://dx.doi.org/10.1097/00126334-200204150-00006

Cardiello P; van Heeswijk RP; Hassink EA; Srasuebkul P; Mahanontharit A; Samor TM; Worarien W; Beijnen JH; Hoetelmans RM; Ruxrungtham K; Cooper DA; Lange JM; Phanuphak P, 2002, 'Simplifying protease inhibitor therapy with once-daily dosing of saquinavir soft-gelatin capsules/ritonavir (1600/100mg):HIVNAT 001.3 study', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 29, pp. 464 - 470

Conference Papers

Cuypers M; Naaldenberg J; Bloemendal H; Leusink G; Srasuebkul P, 2024, 'CANCER INCIDENCE AMONG PEOPLE WITH INTELLECTUAL DISABILITIES IN THE NETHERLANDS - A POPULATION-BASED COHORT STUDY', in JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, WILEY, pp. 754 - 754

Trollor J; Srasuebkul P, 2024, 'DISABILITY DATA LINKAGE CAPACITY IN AUSTRALIA: DEVELOPMENTS AND IMPLICATIONS FOR PEOPLE WITH INTELLECTUAL AND DEVELOPMENTAL DISABILITIES', in JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, WILEY, pp. 768 - 768

Trollor J; Srasuebkul P, 2024, 'DISABILITY DATA LINKAGE CAPACITY IN AUSTRALIA: DEVELOPMENTS AND IMPLICATIONS FOR PEOPLE WITH INTELLECTUAL AND DEVELOPMENTAL DISABILITIES', in JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, WILEY, pp. 768 - 769

Weise J; Srasuebkul P; Vajdic C; Nguyem E; Trollor J, 2024, 'PARTICIPATION IN A MAMMOGRAPHIC SCREENING PROGRAMME FOR WOMEN WITH INTELLECTUAL DISABILITY: A POPULATION-BASED RETROSPECTIVE COHORT STUDY', in JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, WILEY, pp. 758 - 758

Back to profile page